Stopping Ozempic may raise heart attack and stroke risk
A WashU Medicine study of 333,687 veterans with type 2 diabetes found that two years off GLP-1 drugs was linked to a 22% higher risk of heart attack, stroke and death versus continuous use. Restarting treatment only partially restored the cardiovascular benefit.